J2710 HCPCS Level II code: Injection, neostigmine methylsulfate, up to 0.5 mg

J2710 is the HCPCS code for “Injection, neostigmine methylsulfate, up to 0.5 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.

Official description

J2710

Injection, neostigmine methylsulfate, up to 0.5 mg

Short description: Neostigmine methylslfte inj

HCPCS · United States

Medicare details

The indicators CMS publishes with J2710 in its October 2026 file. They describe Medicare’s handling, not another payer’s.

Medicare coverage
Special coverage instructions apply
Medicare pricing
Drugs
Type of service
Medical care; Lump sum purchase of DME, prosthetics, orthotics
BETOS category
Other drugs
Added
Jan 1, 1982

Where J2710 sits

  1. 1J codesDrugs administered other than orally
  2. 2Active code J2710Injection, neostigmine methylsulfate, up to 0.5 mg

Source and release

Data release
HCPCS Level II · October 2026
Effective date
Oct 1, 2026
Publisher
CMS

This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.

Frequently asked questions

What does HCPCS code J2710 mean?

J2710 is the HCPCS code for “Injection, neostigmine methylsulfate, up to 0.5 mg” in CMS’s HCPCS Level II October 2026 release.

Does Medicare cover J2710?

CMS lists J2710’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.

Which HCPCS Level II release does this page use?

It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.